AU755900C - Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects - Google Patents

Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects

Info

Publication number
AU755900C
AU755900C AU31466/99A AU3146699A AU755900C AU 755900 C AU755900 C AU 755900C AU 31466/99 A AU31466/99 A AU 31466/99A AU 3146699 A AU3146699 A AU 3146699A AU 755900 C AU755900 C AU 755900C
Authority
AU
Australia
Prior art keywords
tectorigenin
estrogen
organ
extracts
utilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU31466/99A
Other languages
English (en)
Other versions
AU755900B2 (en
AU3146699A (en
Inventor
Volker Christoffel
Hubertus Jarry
Michael Popp
Barbara Spengler
Wolfgang Wuttke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bionorica SE
Original Assignee
Bionorica SE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7861630&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU755900(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bionorica SE filed Critical Bionorica SE
Publication of AU3146699A publication Critical patent/AU3146699A/en
Assigned to BIONORICA AG reassignment BIONORICA AG Amend patent request/document other than specification (104) Assignors: BIONORICA ARZNEIMITTEL GMBH
Publication of AU755900B2 publication Critical patent/AU755900B2/en
Application granted granted Critical
Publication of AU755900C publication Critical patent/AU755900C/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU31466/99A 1998-03-19 1999-03-19 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects Ceased AU755900C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19812204A DE19812204A1 (de) 1998-03-19 1998-03-19 Verwendung von Extrakten aus Cimicifuga racemosa und Belamcanda sinensis als estrogenartiges organselektives Arzneimittel ohne uterotrope Wirkung
DE19812204 1998-03-19
PCT/EP1999/001860 WO1999047149A1 (de) 1998-03-19 1999-03-19 Verwendung von extrakten aus irisgewächsen und cimicifuga racemosa und tectorigenin als estrogenartiges organselektives arzneimittel ohne uterotrope wirkung

Publications (3)

Publication Number Publication Date
AU3146699A AU3146699A (en) 1999-10-11
AU755900B2 AU755900B2 (en) 2003-01-02
AU755900C true AU755900C (en) 2005-04-21

Family

ID=7861630

Family Applications (1)

Application Number Title Priority Date Filing Date
AU31466/99A Ceased AU755900C (en) 1998-03-19 1999-03-19 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects

Country Status (20)

Country Link
EP (1) EP1064009B2 (https=)
JP (2) JP2002506827A (https=)
KR (1) KR100623333B1 (https=)
CN (2) CN100581541C (https=)
AT (1) ATE225182T1 (https=)
AU (1) AU755900C (https=)
BR (1) BR9908256A (https=)
CA (1) CA2321444C (https=)
CZ (1) CZ292684B6 (https=)
DE (2) DE19812204A1 (https=)
DK (1) DK1064009T4 (https=)
ES (1) ES2184427T5 (https=)
HU (1) HU227694B1 (https=)
MX (1) MXPA00007986A (https=)
PL (1) PL194096B1 (https=)
PT (1) PT1064009E (https=)
RU (2) RU2228188C2 (https=)
SE (1) SE1064009T4 (https=)
TR (1) TR200002686T2 (https=)
WO (1) WO1999047149A1 (https=)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000302667A (ja) * 1999-04-23 2000-10-31 Kobe Tennenbutsu Kagaku Kk 豊胸促進剤
CA2414247C (en) * 2000-06-29 2012-11-27 Quick-Med Technologies, Inc. Cosmetic composition and method comprising a hydroxamate mmpi and a triterpenoid glycoside
TWI303990B (en) 2000-10-17 2008-12-11 Pfizer Prod Inc New use of estrogen agonists/antagonists for improving vascular health
DE10054641A1 (de) 2000-11-03 2002-05-16 Schaper & Bruemmer Gmbh Verwendung einer Zubereitung von Cimicifuga racemosa
DE10123503A1 (de) * 2001-05-15 2002-11-21 Bionorica Ag Verwendung von Extrakten und Zubereitungen aus Irisgewächsen und Tectorigenin als organselektives Arzneimittel zur Behandlung von sexualhormon-abhängigen Erkrankungen des Urogenitaltraktes
DE10127897B4 (de) * 2001-06-08 2006-04-20 Bionorica Ag Manteltablette mit Pflanzentrockenextrakten
DE10146159A1 (de) * 2001-09-19 2003-04-10 Bionorica Ag Verwendung von Extrakten aus Cimicifuga-Arten als organselektives Arzneimittel zur Behandlung von sexualhormonabhängigen Erkrankungen des Urogenitaltraktes
EP1325681A1 (en) * 2001-12-11 2003-07-09 Société des Produits Nestlé S.A. Composition for promotion of bone growth and maintenance of bone health
DE10206390A1 (de) * 2002-02-15 2003-08-28 Bionorica Ag Verwendung von selektiv den Estrogenrezeptor beta modulierenden phytoestrogenhaltigen Extrakten
JP4605984B2 (ja) * 2002-12-20 2011-01-05 アサヒビール株式会社 ストレス緩和剤
DE602004020463D1 (de) * 2003-05-15 2009-05-20 Chengdu Dikang Pharmaceutical Isoflavonderivative von tectoridin, deren herstellung und antivirale medikamente, die diese als wirksame bestandteile enthalten
EP1588739A1 (en) * 2004-04-23 2005-10-26 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
EP1591143A1 (en) * 2004-04-26 2005-11-02 Schaper & Brümmer Gmbh & Co. Kg Composition comprising a combination of Calcium, Cimicifugae racemosae rhizoma and vitamin D and its use as a pharmaceutical in conditions or disorders associated with or resulting from calcium deficiency or as a nutritional supplement
US7887851B2 (en) 2004-06-07 2011-02-15 Kao Corporation Aromatase activator
CN100381435C (zh) * 2005-03-24 2008-04-16 深圳海王药业有限公司 射干总黄酮提取物及其制备方法和其在药物制备中的应用
EP1745796A1 (de) 2005-07-19 2007-01-24 Bionorica Research GmbH Kombinationspräparat insbesondere zur Therapie des Prostatakarzinoms
CN101057854B (zh) * 2006-05-31 2010-05-12 南京大学 升麻环菠萝蜜烷型三萜类化合物在抗骨质疏松及更年期综合症的用途
DE102007044916A1 (de) 2007-09-19 2009-04-23 Bionorica Ag Kosmetische oder dermatologische Zusammensetzung zur topischen Verwendung
KR100928013B1 (ko) * 2008-01-25 2009-11-24 이화여자대학교 산학협력단 범부채 추출물을 이용한 돌피의 생장 촉진방법 및 이방법을 적용한 중금속 오염 토양의 정화방법
CN101797265A (zh) * 2010-04-09 2010-08-11 中国人民解放军第二军医大学 射干总异黄酮或异黄酮类化合物在制备防治妇女病的药物或食品中的应用
EP2545932A1 (de) 2011-07-12 2013-01-16 Bionorica Se Ausgewählte Cimicifuga-Fraktionen zur Behandlung von Osteoporose
WO2013007807A1 (de) 2011-07-12 2013-01-17 Bionorica Se Ausgewählte cimicifuga-fraktionen zur behandlung von osteoporose
EP2620155A1 (de) 2012-01-30 2013-07-31 Bionorica SE Arzneimittel enthaltend Cimicifuga zur Anwendung bei der Behandlung von Sarkopenie und Herzmuskelschwäche
CN102525907B (zh) * 2012-02-22 2013-06-05 四川省中医药科学院 鸢尾苷元磺酸钠注射液
CN102631363A (zh) * 2012-04-11 2012-08-15 李超生 鸢尾苷在制备防治骨质疏松症的药物中的应用
KR20150018831A (ko) * 2012-06-22 2015-02-24 골든 바이오테크놀러지 코포레이션 동맥경화성 혈관 질환을 치료하기 위한 방법 및 조성물
AU2013285492B2 (en) 2012-07-03 2015-11-12 Max Zeller Soehne Ag Novel pharmacological use of Cimicifuga extract
JP2014091706A (ja) * 2012-11-02 2014-05-19 Kao Corp Ｇｌｐ−１分泌促進剤
KR101965849B1 (ko) * 2017-03-07 2019-04-04 주식회사 엘지생활건강 텍토리게닌 7-0-자일로실글루코시드를 포함하는 여성 갱년기 증상 완화용 조성물
KR101964841B1 (ko) * 2017-03-07 2019-08-07 주식회사 엘지생활건강 여성 갱년기 증상 개선용 조성물
TWI761372B (zh) * 2017-09-22 2022-04-21 日商東洋新藥股份有限公司 組合物
WO2020141083A1 (en) 2018-12-31 2020-07-09 Max Zeller Soehne Ag Combination of cimicifuga and petasites extracts for anticancer therapy and prophylaxis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6330417A (ja) * 1986-07-23 1988-02-09 Tsumura Juntendo Inc 抗アレルギ−剤
US5411733A (en) * 1992-04-27 1995-05-02 Hozumi; Toyoharu Antiviral agent containing crude drug
RU2012348C1 (ru) * 1992-10-30 1994-05-15 Анна Геннадиевна Пономарева Сбор лекарственных трав, обладающий общеукрепляющим действием, "нежность", "осень", "наташа"
ES2132855T3 (es) * 1995-09-07 1999-08-16 Oreal Extracto de iridaceas y composiciones que lo contienen.
KR19990067010A (ko) * 1995-10-23 1999-08-16 오스테오스크린, 인코포레이티드 골결핍 상태의 치료용 조성물 및 그 치료방법
JPH09301884A (ja) * 1996-05-15 1997-11-25 Ichimaru Pharcos Co Ltd ヒオウギ抽出物及びα−ヒドロキシ酸を含有するテストステロン５α−リダクターゼ阻害剤とその応用
JPH107580A (ja) * 1996-06-15 1998-01-13 Michio Yoshida コラゲナ−ゼ阻害剤
JP3665848B2 (ja) * 1996-09-18 2005-06-29 木村 幸代 ヒメヒオウギズイセン球根抽出液の発酵飲料及びその製造方法
US5753266A (en) * 1996-12-03 1998-05-19 Youssefyeh; Parvin Safflower seed powder compositions for the treatment of rheumatoid based arthritic diseases
DE19652183C1 (de) * 1996-12-14 1998-02-12 Schaper & Bruemmer Gmbh Verwendung eines Extraktes aus Cimicifuga racemosa
RU2114629C1 (ru) * 1997-04-10 1998-07-10 Бабаскина Людмила Ивановна Сбор лекарственных трав, обладающий общеукрепляющим и нормализующим гормональный статус в климактерическом периоде действием

Also Published As

Publication number Publication date
SE1064009T4 (sv) 2008-09-23
ES2184427T5 (es) 2008-12-16
EP1064009A1 (de) 2001-01-03
EP1064009B2 (de) 2008-07-30
DK1064009T3 (da) 2002-11-04
HU227694B1 (en) 2011-12-28
RU2228188C2 (ru) 2004-05-10
DE59902932D1 (de) 2002-11-07
CN1509712A (zh) 2004-07-07
KR20010040829A (ko) 2001-05-15
HUP0200921A3 (en) 2004-05-28
JP2002506827A (ja) 2002-03-05
RU2263505C2 (ru) 2005-11-10
MXPA00007986A (es) 2002-08-06
HUP0200921A2 (hu) 2002-12-28
EP1064009B9 (de) 2003-02-05
PL342486A1 (en) 2001-06-04
SE1064009T3 (sv) 2003-01-21
CZ20002810A3 (cs) 2000-12-13
TR200002686T2 (tr) 2000-12-21
DE19812204A1 (de) 1999-11-04
ATE225182T1 (de) 2002-10-15
HK1035660A1 (en) 2001-12-07
WO1999047149A1 (de) 1999-09-23
BR9908256A (pt) 2000-12-12
AU755900B2 (en) 2003-01-02
DK1064009T4 (da) 2008-08-25
RU2003137324A (ru) 2005-06-10
PL194096B1 (pl) 2007-04-30
KR100623333B1 (ko) 2006-12-05
CN100581541C (zh) 2010-01-20
CA2321444A1 (en) 1999-09-23
JP2010132699A (ja) 2010-06-17
CN1293575A (zh) 2001-05-02
EP1064009B1 (de) 2002-10-02
CZ292684B6 (cs) 2003-11-12
ES2184427T3 (es) 2003-04-01
AU3146699A (en) 1999-10-11
CN100444867C (zh) 2008-12-24
SE1064009T5 (sv) 2003-04-15
PT1064009E (pt) 2003-02-28
CA2321444C (en) 2012-10-02

Similar Documents

Publication Publication Date Title
AU755900C (en) Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
WO2002047706A3 (en) Selective cox-2 inhibition from plant extracts
DK0835120T3 (da) Farmaceutiske sammensætninger indeholdende aktive ingredienser på basis af urter, fremgangsmåde til fremstilling af sammens
WO1999066913A3 (en) Composition for the prevention and/or treatment of osteoporosis and alterations due to menopause syndrome, comprising propionyl-l-carnitine and genistein
WO2002047708A3 (en) Selective cox-2 inhibition from edible plant extracts
CA2330128A1 (en) Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
NO963378L (no) Behandling av antibiotisk assosiert diare
EP0846466A3 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
TR200002770T2 (tr) Estrojene bağlı bozuklukların tedavisi
EP0813875A3 (en) Inhibition of abnormal accumulation of extracellular matrices
WO2000010507A3 (en) Use of melanin for inhibition of angiogenesis and macular degeneration
WO2001051043A3 (en) Compositions and methods for treatment of neoplastic diseases with combinations of limonoids, flavonoids and tocotrienols
BR0010119A (pt) Composição para prevenir ou tratar da demência contendo um derivado do ácido hidroxicinâmico ou um extrato de uma planta do genus angelicae contendo o mesmo
MX2010003726A (es) Composiciones herbarias y metodos de tratamiento de trastornos hepaticos.
EP0315378A3 (en) Manufacture of medicaments for treating viral skin infections
AU8369198A (en) Method of preparation and pharmaceutical composition of an uncaria water solubleextract
AU5878098A (en) Composition of a dietary product that is effective to combat oxidative stress and cell decay
GR3036569T3 (en) Process for extraction of polyphenolic compounds of catechin type from plants, the so obtained extract and its use
NZ523446A (en) (Aminoalkylbenzoyl) benzofuran or benzothiophene, their process of prepation and the compositions comprising them
NO975858D0 (no) Anvendelse av et ekstrakt av Cimicifuga racemosa
MXPA01011924A (es) Metodos y composiciones para modular la respuesta inmunitaria y para el tratamiento de trastornos inflamatorios.
DK1331939T3 (da) Murraya koenigii-ekstrakter til behandling af astma
WO2001090064A3 (en) COMPOSITION AND METHOD CONTAINING PRODUCTS EXTRACTED FROM COMMIPHORA Sp. FOR PREVENTION AND TREATMENT OF ABNORMAL CELL GROWTH AND PROLIFERATION IN INFLAMMATION, NEOPLASIA AND CARDIOVASCULAR DISEASE
WO1997034932A3 (en) Compositions containing starch excipients
WO2001097771A3 (de) Zubereitungen enthaltend einen extrakt der pflanze pistia stratiotes

Legal Events

Date Code Title Description
TC Change of applicant's name (sec. 104)

Owner name: BIONORICA AG

Free format text: FORMER NAME: BIONORICA ARZNEIMITTEL GMBH

CB Opposition filed

Opponent name: SCHAPER AND BRUMMER GMBH AND CO. KB

CH Opposition withdrawn

Opponent name: SCHAPER AND BRUMMER GMBH AND CO. KB

NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 20040201 TO 20040801 IN WHICH TO PROVIDE SEARCH RESULTS UNDER S45(3) HAS BEEN FILED